Technology transfer process excellence with an AAV comparability study

Cell and Gene Therapy Insights 2023; 9(6), 1011


Published: 2 September 2023
Isabel Guerrero Montero

Watch the video or view the poster to learn about: 

  • How to achieve technology transfer excellence with a phased approach and a core support team that is in frequent, transparent communication with the client throughout each phase. 
  • The key phases in the technology transfer process, including aligning on process description, completing a gap analysis and risk assessment, performing a comparability protocol, defining the process at the commercial scale, and executing the batches and final reports. 
  • A recent comparability study that supports the successful technical transfer of an AAV clinical program to Viralgen’s commercial facility at the 500 L scale.